Inactive Instrument

Press Releases Healthwell Acquisition Corp. I

Equities

HWEL

US42227R1095

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

HEALTHWELL ACQUISITION CORP. I ANNOUNCES CANCELLATION OF SPECIAL STOCKHOLDER MEETING AND ITS INTENTION TO LIQUIDATE	11-20	AQ
Healthwell Acquisition Corp. I Announces Cancellation of Special Stockholder Meeting and its Intention to Liquidate	11-17	BU
Starton Therapeutics Announces Termination of Business Combination Agreement with Healthwell Acquisition Corp. I	11-06	AQ
Healthwell Acquisition Corp. I Announces Termination of Business Combination with Starton Therapeutics, Inc.	11-03	BU
Healthwell Acquisition Corp. I Announces Postponement of the Special Meeting of Stockholders to Approve the Proposed Business Combination with Starton Therapeutics, Inc. and Related Transactions	23-10-23	BU
Healthwell Acquisition Corp. I Announces New Meeting Date for the Special Meeting of Stockholders to Approve Proposed Business Combination With Starton Therapeutics, Inc. and Related Transactions	23-10-17	BU
Starton Therapeutics Doses First Patient in Landmark STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple Myeloma	23-10-04	BU
Starton Therapeutics Announces the Opening of the First Clinical Site for STAR-LLD Lenalidomide Phase 1b Trial in Multiple Myeloma	23-09-13	BU
Starton Therapeutics Contracts Global Clinical Research Organization to Conduct STAR-LLD Phase 1b Clinical Trial in Multiple Myeloma	23-07-10	BU
Healthwell Acquisition I : Shareholder Director Nominations - Form 8-K	23-06-29	PU
HEALTHWELL ACQUISITION CORP. I : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-06-13	AQ
Starton Therapeutics Receives Authorization from the FDA to Proceed with STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple Myeloma	23-06-12	BU
Starton Therapeutics, Inc. and Healthwell Acquisition Corp. I to Present at the Jefferies Healthcare Conference	23-06-06	BU
HEALTHWELL ACQUISITION CORP. I : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	23-05-15	AQ
HEALTHWELL ACQUISITION CORP. I : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	23-05-03	AQ
HEALTHWELL ACQUISITION CORP. I : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-04-27	AQ
Starton Therapeutics Inc. and Healthwell Acquisition Corp. I to Combine and Create Publicly Traded Leader in Proprietary Continuous Delivery Technology for Cancer Treatments	23-04-27	BU
HEALTHWELL ACQUISITION CORP. I : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	23-03-23	AQ
HEALTHWELL ACQUISITION CORP. I Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	23-03-03	AQ
HEALTHWELL ACQUISITION CORP. I MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	22-11-10	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Healthwell Acquisition Corp. I

Equities

HWEL

US42227R1095

Press Releases

Filters